Cresco Labs Inc. (CRLBF): Cash & Equivalents

Annual figures by period end, from SEC filings.

$57.90M
As of 2025-12-31
$137.56M2023-12-31: $103.43M2024-12-31: $137.56M2025-12-31: $57.90M$57.90M
2023-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$57.90M-57.9%2026-03-06, Balance as of period end
2024-12-31$137.56M+33.0%2026-03-06, Balance as of period end
2023-12-31$103.43Mn/a2025-03-14, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31$57.90M-57.9%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$85.68M-2.9%
Tilray Brands, Inc. (TLRY)2026-05-31$225.98M+1.9%
USANA Health Sciences Inc (USNA)2026-01-03$158.38M-12.9%
Trulieve Cannabis Corp. (TRLV)2025-12-31$255.53M+7.0%
Jushi Holdings Inc. (JUSH)2025-12-31$24.05M+23.2%
biote Corp. (BTMD)2025-12-31$24.12M-38.7%
Marimed Inc. (MRMD)2024-12-31$7.28M-50.3%
Cronos Group Inc. (CRON)2025-12-31$791.79M-7.8%

Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗